Masayuki Kohno

988 total citations
36 papers, 843 citations indexed

About

Masayuki Kohno is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Masayuki Kohno has authored 36 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Masayuki Kohno's work include Monoclonal and Polyclonal Antibodies Research (11 papers), RNA Interference and Gene Delivery (5 papers) and Peptidase Inhibition and Analysis (5 papers). Masayuki Kohno is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), RNA Interference and Gene Delivery (5 papers) and Peptidase Inhibition and Analysis (5 papers). Masayuki Kohno collaborates with scholars based in Japan, Norway and United States. Masayuki Kohno's co-authors include Koji Kawakami, Tomohisa Horibe, Koji Ohara, Sho Yamasaki, Mari Haramoto, Takashi Saito, Arong Gaowa, Victor L. J. Tybulewicz, Eri Ishikawa and Oumi Nakajima and has published in prestigious journals such as Blood, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Masayuki Kohno

35 papers receiving 832 citations

Peers

Masayuki Kohno

IMMUN

ONCOL

BIOMA

RNMI

Barbara Richichi Italy

Domenica Capasso Italy

Benjamin Bruno United States

Sara La Manna Italy

Kentaro Takayama Japan

Annarita Del Gatto Italy

Anabel Sorolla Spain

Myung Kyu Lee South Korea

Niranjan B. Pandey United States

Barbara Richichi Italy

Masayuki Kohno

689 ×1.6

164 ×0.8

IMMUN

166 ×0.9

ONCOL

87 ×0.7

BIOMA

90 ×1.0

RNMI

Citations per year, relative to Masayuki Kohno Masayuki Kohno (= 1×) peers Barbara Richichi

Countries citing papers authored by Masayuki Kohno

Since Specialization

Citations

This map shows the geographic impact of Masayuki Kohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Kohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Kohno more than expected).

Fields of papers citing papers by Masayuki Kohno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Kohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Kohno. The network helps show where Masayuki Kohno may publish in the future.

Co-authorship network of co-authors of Masayuki Kohno

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Kohno. A scholar is included among the top collaborators of Masayuki Kohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Kohno. Masayuki Kohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaowa, Arong, Tomohisa Horibe, Masayuki Kohno, & Koji Kawakami. (2017). Bile Acid as an Effective Absorption Enhancer for Oral Delivery of Epidermal Growth Factor Receptor–Targeted Hybrid Peptide. Journal of Pharmaceutical Sciences. 107(5). 1322–1329. 14 indexed citations

Kikuchi, Osamu, Shinya Ohashi, Tomohisa Horibe, et al.. (2016). Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma. Scientific Reports. 6(1). 22452–22452. 13 indexed citations

Gaowa, Arong, Tomohisa Horibe, Masayuki Kohno, et al.. (2015). Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers. European Journal of Pharmaceutics and Biopharmaceutics. 92. 228–236. 19 indexed citations

Kohno, Masayuki, Tomohisa Horibe, Koji Ohara, Shinji Ito, & Koji Kawakami. (2014). The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure. Chemistry & Biology. 21(11). 1522–1532. 31 indexed citations

Gaowa, Arong, Tomohisa Horibe, Masayuki Kohno, et al.. (2014). Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo. Journal of Controlled Release. 176. 1–7. 66 indexed citations

Horibe, Tomohisa, et al.. (2013). HER2-Targeted Hybrid Peptide That Blocks HER2 Tyrosine Kinase Disintegrates Cancer Cell Membrane and Inhibits Tumor Growth In Vivo. Molecular Cancer Therapeutics. 12(4). 384–393. 30 indexed citations

Ohara, Koji, Masayuki Kohno, Tsutomu Hamada, & Koji Kawakami. (2013). Entry of a cationic lytic-type peptide into the cytoplasm via endocytosis-dependent and -independent pathways in human glioma U251 cells. Peptides. 50. 28–35. 8 indexed citations

Kohno, Masayuki, et al.. (2013). Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent. Cancer Chemotherapy and Pharmacology. 71(3). 799–807. 10 indexed citations

Horibe, Tomohisa, et al.. (2012). Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells. Molecular Cancer. 11(1). 59–59. 28 indexed citations

10.

Yang, Liying, Tomohisa Horibe, Masayuki Kohno, et al.. (2011). Targeting Interleukin-4 Receptor α with Hybrid Peptide for Effective Cancer Therapy. Molecular Cancer Therapeutics. 11(1). 235–243. 33 indexed citations

11.

Horibe, Tomohisa, Masayuki Kohno, Mari Haramoto, Koji Ohara, & Koji Kawakami. (2011). Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. Journal of Translational Medicine. 9(1). 8–8. 53 indexed citations

12.

Horibe, Tomohisa, et al.. (2011). Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer. Biochemical and Biophysical Research Communications. 414(1). 60–66. 26 indexed citations

13.

Tada, Noriko, Tomohisa Horibe, Mari Haramoto, et al.. (2011). A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity. Biochemical and Biophysical Research Communications. 407(2). 383–388. 32 indexed citations

14.

Horibe, Tomohisa, et al.. (2011). A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. BMC Cancer. 11(1). 359–359. 65 indexed citations

15.

Ohara, Koji, Tomohisa Horibe, Masayuki Kohno, & Koji Kawakami. (2011). Characterization of antilytic peptide antibody: application for the detection of lytic‐based hybrid peptide in serum samples. Journal of Peptide Science. 17(7). 493–498. 9 indexed citations

16.

Kohno, Masayuki, Tomohisa Horibe, Mari Haramoto, et al.. (2010). A novel hybrid peptide targeting EGFR-expressing cancers. European Journal of Cancer. 47(5). 773–783. 64 indexed citations

17.

Suenaga, Tadahiro, Hisashi Arase, Sho Yamasaki, et al.. (2007). Cloning of B cell‐specific membrane tetraspanning molecule BTS possessing B cell proliferation‐inhibitory function. European Journal of Immunology. 37(11). 3197–3207. 8 indexed citations

18.

Kimura, Yoshimitsu, et al.. (2002). P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel. Cancer Chemotherapy and Pharmacology. 49(4). 322–328. 43 indexed citations

19.

Kohno, Masayuki, et al.. (2000). G_i1 and G_oA differentially determine kinetic efficacies of agonists for κ‐opioid receptor. FEBS Letters. 473(1). 101–105. 11 indexed citations

20.

Fukushima, Nobuyuki, Masayuki Kohno, Takeshi Kato, et al.. (1998). Melittin, a Metabostatic Peptide Inhibiting Gs Activity. Peptides. 19(5). 811–819. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact